HIV Flashcards

1
Q

Which is more prevalent? HIV 1 or HIV2

A

HIV-1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which HIV-1 Group is the most common globally? (M/ N/ O/ P)

A

M

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Which subtype or clade of HIV is most common in US & EU?

A

B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Top 3 causes of HIV

A

Blood transfusions, Anal Sex: Receptive partner’s risk (w/ ejaculation), Needle sharing (injection drug use)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

HIV risk factors

A
  • Viral load
  • Sexual behavior
  • Sexually transmitted infections
  • Lack of circumcision
  • Genetic background
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Hallmarks of HIV

A
  • High replication rate
  • High error rate
  • Plastic envelope
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

HIV Cell Cycle

A

Step 1: HIV attaches to a CD4 receptor on the cell membrane of the host cell
Step 2: HIV fuses with the cell membrane and releases its contents into the host cell
Step 3: HIV’s protein coat degrades. HIV’s RNA and reversible transcriptase are released into cell cytoplasm.
Step 4: Reverse transcriptase rewrites HIV’s single - stranded RNA as HIV’s double stranded DNA.
Step 5: HIV’s DNA enters the host cell’s nucleus and is then inserted into the DNA of a host cell chromosome
Step 6: Many copies of single-stranded HIV RNA are made. They direct the synthesis of HIV’s proteins
Step 7: HIV RNA and proteins gather at the cell membrane and leave the host cell as an immature virus
Step 8: HIV RNA and proteins are reassembled to form a mature virus which goes on to infect other cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Chronic T cell activation leads to:

A

*Death of infected cells (cytopathic effect of virus)* due to viral replication in infected CD4+ T cells

*Activation-induced cell death (apoptosis)* due to activation of uninfected CD4+ T cells

*Killing of infected cells by virus-specific cytotoxic T lymphocytes* due to expression of HIV peptides on infected CD4+ T cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

CD4 cells:

  • % turnover daily
  • relationship with mortality
A

6-7%

Decreased CD4 cells = increased probability of AIDS or death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is critical in monitoring virologic response to anti-retroviral therapy?

A

Viral load

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Viral load:

  • half life inside & outside cell
  • % viral burden turned over daily
A
  • 24 hour inside & 6 hours outside
  • 30%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Acute HIV Infection:

  • How long does it take for this to occur after HIV exposure?
  • How long does this phase last?
  • Symptoms strongest? Time frame
  • Antibody test results: Time frame
A
  • 2-3+ weeks
  • 1-3 months
  • 2-3+ weeks
  • Negative: 2-3 weeks, Positive: rest of acute HIV infection phase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Main Symptoms of HIV infection:

A
  • Fever
  • Weight loss
  • Pharyngitis
  • Sores and thrush in mouth
  • Sores in esophagus
  • Myalgia
  • Liver & spleen enlargement
  • Malaise
  • Headache
  • Neuropathy
  • Lymphadenopathy
  • Rash
  • N/V
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Chronic/ Latent HIV infection: Asymptomatic & Symptomatic [Characteristics]

A

Asymptomatic:

  • Persistent generalized lymphadenopathy (Symmetrical, modestly enlarged, cervical, submandibular, occipital, axillary)
  • Further evaluation not necessary

Symptomatic:

  • Occurs especially as CD4 count decreases
  • Skin & mucous membrane involvement
  • Thrush, skin & soft tissue infection, rashes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Patho of progression:

(a) Types
(b) Compartmentalization
(c) Cell affected

A

(a) Types: Rapid progressors, long-term non-progressors, elite controllers
(b) Gut associated lymphoid tissue, brain tissue, kidneys, liver

(c)

  • T-cell homeostasis affected
  • Disrupted lymph-node architecture
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

AIDS progression signs

A
  • CD4 count: <200 [Increased viremia, significant cell reduction]
  • AIDS Defining Illness:
    Spectrum: multi-organs, CNS, blood
    Cryptococcosis
    Cytomegalovirus disease or CMV
    Herpes Simplex
    Mycobacterium
    Pneumocystitis pneumonia
    Kaposi sacroma
    Several varieties of lymphomas
  • Mean survival time: 12-18 months without combination antiretroviral therapy
17
Q

HIV and AIDS- CNS effects:

a) Complications
b) Most common manifestation
c) Patho

A

a)

  • Aseptic meningitis and acute demyelinating polyneuropathy
  • HIV- Associated Neurocognitive Deficits (HANS)
  • Vacuolar myelopathy (most common chronic myelopathy)
  • Hemorrhagic and ischemic stroke

b) HIV- Associated Neurocognitive Deficits (HANS)

c)

  • HIV targets astrocytes and perivascular macrophages/microglial cells
    • Astrocytes act as reservoir
  • Neurons are not directly infected
    • GP120 and Tat – HIV proteins that are known to be neurotoxic
  • Replication of HIV in the CNS
    • stimulation of proinflammatory cytokines and neurotoxins
18
Q

HIV Testing: Who To Test?

A
  • Symptoms of Acute or Chronic Infection
  • Anyone with Possible Exposure
  • Pregnant Women
  • Routine Health Screens – One Time Tests
  • Even for those “without” risk factors
    • Ages 13 – 65
  • Annual Testing for “High Risks”
    • Men who have sex with men (q3-6m) and their partners
    • IVDU
    • Transactional Sex
19
Q

What do the 4th generation HIV diagnostic tests detect? How long does it take?

A

IgM, IgG Antibody, p24 Antigen

15-20 days

20
Q

What drugs are potential targets for interruption of HIV replication cycle?

A
  • Reverse transcriptase inhibitors
  • Entry inhibitors fusion and penetration
  • Chemokine antagonists
  • Integration, transcription, and translation inhibitors
  • Viral Maturation inhibitors